Therefore, we herein performed a systematic literature review to examine the effects of primary prophylaxis with G-CSF for AML, which will provide more precise estimates of its clinical efficacy and toxicity as well as serve as the basis for updates to clinical practice guidelines. Here, CSF3 is linked to acute myeloid leukemia.